tiprankstipranks
Advertisement
Advertisement

VALN Stock Latest News

Valneva Shareholders Back All AGM Resolutions as Board Elects New Chair
Company AnnouncementsValneva Shareholders Back All AGM Resolutions as Board Elects New Chair
10d ago
6K
VALN
Valneva Publishes Documentation for June 25, 2026 Annual General Meeting
PremiumCompany Announcements
Valneva Publishes Documentation for June 25, 2026 Annual General Meeting
30d ago
6K
VALN
Valneva files to sell 31.79M ordinary shares for holders
PremiumThe Fly
Valneva files to sell 31.79M ordinary shares for holders
1M ago
VALN
Valneva Ramps Up June 2026 Investor and Medical Conference Presence
PremiumCompany Announcements
Valneva Ramps Up June 2026 Investor and Medical Conference Presence
1M ago
6K
VALN
Valneva Tightens 2026 Guidance and Restructures as Lyme Vaccine Nears Regulatory Filings
PremiumCompany Announcements
Valneva Tightens 2026 Guidance and Restructures as Lyme Vaccine Nears Regulatory Filings
2M ago
6K
VALN
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsVALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
VALN
Valneva Sets May 13 Date to Present First-Quarter 2026 Results
Premium
Company Announcements
Valneva Sets May 13 Date to Present First-Quarter 2026 Results
2M ago
6K
VALN
Valneva Raises Up to €84 Million via Private Placement Tied to Lyme Vaccine Milestone
Premium
Company Announcements
Valneva Raises Up to €84 Million via Private Placement Tied to Lyme Vaccine Milestone
2M ago
6K
VALN
Valneva downgraded to Sell from Neutral at Goldman Sachs
PremiumThe Fly
Valneva downgraded to Sell from Neutral at Goldman Sachs
2M ago
VALN
Valneva price target lowered to $11 from $13 at Guggenheim
PremiumThe Fly
Valneva price target lowered to $11 from $13 at Guggenheim
3M ago
VALN
Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington
PremiumCompany Announcements
Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington
3M ago
6K
VALN
Valneva and Pfizer Report Strong Phase 3 Efficacy for Lyme Disease Vaccine Candidate
PremiumCompany Announcements
Valneva and Pfizer Report Strong Phase 3 Efficacy for Lyme Disease Vaccine Candidate
3M ago
6K
VALN
Jefferies says Valneva stock weakness presents buying opportunity
PremiumThe FlyJefferies says Valneva stock weakness presents buying opportunity
3M ago
VALN
Pfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
Premium
Market News
Pfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
3M ago
PFE
VALN
Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
Premium
The Fly
Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
3M ago
PFE
VALN
Valneva Posts 2025 Results, Flags 2026 as Pivotal Year Ahead of Lyme Vaccine Phase 3 Data
PremiumCompany Announcements
Valneva Posts 2025 Results, Flags 2026 as Pivotal Year Ahead of Lyme Vaccine Phase 3 Data
4M ago
6K
VALN
Elaris FlexCo secures exclusive global license from Valneva
PremiumThe Fly
Elaris FlexCo secures exclusive global license from Valneva
4M ago
VALN
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
VALN
Valneva Sets March 18 Date to Release Full-Year 2025 Results
PremiumCompany Announcements
Valneva Sets March 18 Date to Release Full-Year 2025 Results
4M ago
6K
VALN
Valneva Ramps Up Investor Outreach Ahead of Key Lyme Vaccine Data
PremiumCompany AnnouncementsValneva Ramps Up Investor Outreach Ahead of Key Lyme Vaccine Data
4M ago
6K
VALN
Valneva Posts Stable 2025 Revenue, Sets 2026 Outlook Ahead of Key Lyme Vaccine Data
Premium
Company Announcements
Valneva Posts Stable 2025 Revenue, Sets 2026 Outlook Ahead of Key Lyme Vaccine Data
5M ago
6K
VALN
Valneva’s IXCHIQ Chikungunya Vaccine Faces New UK Use Restrictions but Retains Positive Benefit–Risk Profile
Premium
Company Announcements
Valneva’s IXCHIQ Chikungunya Vaccine Faces New UK Use Restrictions but Retains Positive Benefit–Risk Profile
5M ago
6K
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >